Episode 421: 428. Asthma and Stroke --- A breathless combination

Minocycline in Acute Ischemic Stroke (EMPHASIS trial) A multicenter, double-blind RCT in China studied 1,724 patients with acute ischemic stroke treated within 72 hours of onset. Patients received either a 4.5-day course of oral minocycline or placebo. Minocycline works by inhibiting microglial activation , which contributes to post-stroke inflammation. Primary outcome: 52.6% of minocycline patients vs. 47.4% of placebo patients achieved good functional recovery (mRS 0–1) at 90 days (p=0.0061). Safety: No difference in adverse events. Practice impact: Clinicians are cautiously optimistic; further positive trials could lead to selective use of minocycline in AIS patients. 2. Tenecteplase for Basilar Artery Stroke (TRACE-5 trial) This phase 3 RCT in China tested IV tenecteplase given within 24 hours of ischemic basilar artery occlusion against standard medical care (both groups could undergo thrombectomy). Results: At 90 days, 38% of tenecteplase patients vs. 29% of controls had no or minimal disability (mRS 0–1 or baseline). Safety: Similar rates of intracranial hemorrhage (2–3%) and mortality (29–31%). Practice impact: Promising expansion of the thrombolytic window for severe posterior strokes; more evidence needed before routine use outside research settings.

You can listen to Episode 421: 428. Asthma and Stroke --- A breathless combination online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 421: 428. Asthma and Stroke --- A breathless combination is an episode from Questioning Medicine by Questioning Medicine.

This episode is 16:48 long.

This episode was published on Mar 13, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Questioning Medicine when more episodes are available from the podcast feed.